コデイン市場：製剤、グレード、用途、流通チャネル、エンドユーザー別-2025-2030年世界予測

コデイン市場は、2023年に39億3,000万米ドルと評価され、2024年には41億1,000万米ドルに達すると予測され、CAGR 4.65％で成長し、2030年には54億米ドルに達すると予測されています。

コデインは、疼痛、咳、下痢の治療に使用されるアヘン剤であり、疼痛管理における広範な用途と必要性により、医薬品業界で重要な役割を果たしています。コデインは、主に錠剤、カプセル剤、シロップ剤などの処方薬と市販薬をカバーしています。コデインの必要性は、軽度から中等度の痛みを緩和する効能と咳を抑える有用性に由来します。用途としては、コデインは医療提供者によって様々な治療目的で利用され、主に薬局や病院を通じて流通しています。最終用途の範囲には疼痛管理を必要とする患者も含まれ、市場成長を牽引する一定の需要を生み出しています。成長に影響を与える主な要因としては、疼痛管理ソリューションの需要を高める慢性疼痛疾患の発生率の増加、効果的な治療オプションに対する意識の高まりなどが挙げられます。しかし、潜在的な誤用や規制上の制約が市場成長の課題となっており、注目を集めています。オピオイド危機は規制強化につながり、拡大にマイナスの影響を与えています。とはいえ、より安全で中毒性の低いコデイン製剤の開発や、コデイン誘導体の代替天然供給源の探索に新たなビジネスチャンスがあります。さらに、製剤設計における潜在的な技術的進歩は、ドラッグデリバリー方法を強化し、競争優位性をもたらす可能性があります。技術革新はまた、コデインをより持続的に生産するための合成生物学的技術の向上にも焦点を当てることができます。ケシ植物やその生合成経路の遺伝子組み換えを調査することで、コデインの生産効率に関する新たな知見が得られる可能性があります。市場関係者はまた、安全使用の意識を高めるための患者教育プログラムに投資することで、社会的懸念に対処しながら忠実な消費者層を作り出すという利益を得ることができます。これらの戦略は、進化する法的環境の順守と相まって、市場での存在感を強め、持続可能な成長を確実にする可能性があります。

市場力学：急速に進化するコデイン市場の主要市場インサイトを公開

コデイン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疼痛と咳の有病率の増加
  • 規制薬物の安全な流通を確保するための構造化された規制枠組みの利用可能性
• 市場抑制要因
  • コデインの製造・商品化コストの高さ
• 市場機会
  • コデインを革新的かつ効率的に使用するための製薬会社と研究機関の共同開発
  • 放出制御製剤の進歩の高まり
• 市場の課題
  • コデインを使用した偽造品の蔓延

ポーターのファイブフォース：コデイン市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、コデイン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コデイン市場における外部からの影響の把握

外部マクロ環境要因は、コデイン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コデイン市場における競合情勢の把握

コデイン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコデイン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コデイン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨コデイン市場における成功への道筋を描く

コデイン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性的な痛みや咳の症状の増加
    • 規制物質の安全な流通を確保するための構造化された規制枠組みの存在
  • 抑制要因
    • コデインの生産と商品化にかかるコストが高い
  • 機会
    • 製薬企業と調査機関の共同開発によるコデインの革新的かつ効率的な利用
    • 放出制御製剤の進歩
  • 課題
    • コデインによる偽造品の蔓延
• 市場セグメンテーション分析
  • 処方：患者のコンプライアンスが高いため、他の処方よりもシロップが好まれる
  • 用途：呼吸器疾患における咳反射の抑制剤として認識されているコデイン
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 コデイン市場処方別

• カプセル
• シロップ
• 錠剤

第7章 コデイン市場：グレード別

• 実験室グレード
• 医薬品グレード

第8章 コデイン市場：用途別

• 咳止め
• 下痢抑制
• 疼痛管理

第9章 コデイン市場：流通チャネル別

• オフライン
  • 病院・クリニック
  • 薬局
• オンライン

第10章 コデイン市場：エンドユーザー別

• 大人
• 小児科

第11章 南北アメリカのコデイン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のコデイン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのコデイン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 強化鎮痛薬開発の進歩
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Accord Healthcare by Intas Pharmaceuticals
• Advik Pharma
• AstraEureka Pharmaceuticals
• Bristol Laboratories Limited
• Crescent Pharma Limited
• Johnson Matthey Plc
• Noramco, Inc.
• Omnica Laboratories
• Pfizer Inc.
• Professional Compounding Centers of America, Inc.
• SANOFI WINTHROP INDUSTRIE
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. CODEINE MARKET RESEARCH PROCESS
• FIGURE 2. CODEINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CODEINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CODEINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CODEINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CODEINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CODEINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CODEINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CODEINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CODEINE MARKET DYNAMICS
• TABLE 7. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CODEINE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CODEINE MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CODEINE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CODEINE MARKET SIZE, BY LABORATORY GRADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CODEINE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CODEINE MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CODEINE MARKET SIZE, BY DIARRHEA SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CODEINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CODEINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CODEINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CODEINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CODEINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CODEINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. CANADA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. CHINA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SOUTH KOREA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. TAIWAN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. THAILAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. VIETNAM CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 151. DENMARK CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. EGYPT CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. FINLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. FRANCE CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. GERMANY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. ISRAEL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. ITALY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 188. ITALY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 189. ITALY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ITALY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 191. ITALY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 192. ITALY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. NETHERLANDS CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. NIGERIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. NORWAY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. POLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 212. POLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 213. POLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. POLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 215. POLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 216. POLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. QATAR CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 218. QATAR CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 219. QATAR CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. QATAR CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. QATAR CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 222. QATAR CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. RUSSIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. SAUDI ARABIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH AFRICA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. SPAIN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 247. SWEDEN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. SWITZERLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. TURKEY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. UNITED KINGDOM CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 277. CODEINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 278. CODEINE MARKET, FPNV POSITIONING MATRIX, 2023

The Codeine Market was valued at USD 3.93 billion in 2023, expected to reach USD 4.11 billion in 2024, and is projected to grow at a CAGR of 4.65%, to USD 5.40 billion by 2030.

Codeine, an opiate used to treat pain, cough, and diarrhea, plays a crucial role in the pharmaceutical industry due to its widespread application and necessity in pain management. The scope of codeine encompasses prescription and over-the-counter medications, predominantly in the form of tablets, capsules, and syrups. The necessity of codeine stems from its efficacy in providing relief for mild to moderate pain and its utility in suppressing coughs. In terms of application, codeine is utilized by healthcare providers for diverse therapeutic purposes and is primarily distributed through pharmacies and hospitals. The end-use scope includes patients requiring pain management, creating a constant demand that drives market growth. Key factors influencing growth include an increasing incidence of chronic pain conditions, which elevate the demand for pain management solutions, and heightened awareness of effective treatment options. However, the market is gaining attention due to potential misuse and regulatory limitations which challenge its growth. The opioid crisis has led to stricter regulations, negatively impacting expansion. Nevertheless, an emerging opportunity lies in developing safer, less addictive codeine formulations and exploring alternative natural sources for codeine derivatives. Furthermore, potential technological advancements in pharmaceutical formulation design could enhance drug delivery methods, providing a competitive edge. Innovation may also focus on improving synthetic biology techniques to produce codeine more sustainably. Researching genetic modifications in poppy plants or their biosynthetic pathways could yield new insights into codeine production efficiency. Market players can also benefit from investing in patient education programs to enhance safe use awareness, thus creating a loyal consumer base while addressing societal concerns. These strategies, combined with adherence to evolving legal landscapes, could strengthen market presence and ensure sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Codeine Market

The Codeine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic pain and cough conditions
  • Availability of structured regulatory frameworks to ensure the safe distribution of controlled substances
• Market Restraints
  • High costs of production and commercialization of codeine
• Market Opportunities
  • Collaborative developments between pharmaceutical and research institutions to innovative and efficient uses of codeine
  • Rising advancements in controlled-release formulations
• Market Challenges
  • Prevalence of counterfeit products with codeine

Porter's Five Forces: A Strategic Tool for Navigating the Codeine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Codeine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Codeine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Codeine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Codeine Market

A detailed market share analysis in the Codeine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Codeine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Codeine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Codeine Market

A strategic analysis of the Codeine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Codeine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare by Intas Pharmaceuticals, Advik Pharma, AstraEureka Pharmaceuticals, Bristol Laboratories Limited, Crescent Pharma Limited, Johnson Matthey Plc, Noramco, Inc., Omnica Laboratories, Pfizer Inc., Professional Compounding Centers of America, Inc., SANOFI WINTHROP INDUSTRIE, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Codeine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Formulation, market is studied across Capsule, Syrup, and Tablet.
• Based on Grade, market is studied across Laboratory Grade and Pharmaceutical Grade.
• Based on Application, market is studied across Cough Suppression, Diarrhea Suppression, and Pain Management.
• Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Pharmacies.
• Based on End-User, market is studied across Adults and Pediatrics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic pain and cough conditions
    • 5.1.1.2. Availability of structured regulatory frameworks to ensure the safe distribution of controlled substances
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of production and commercialization of codeine
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaborative developments between pharmaceutical and research institutions to innovative and efficient uses of codeine
    • 5.1.3.2. Rising advancements in controlled-release formulations
  • 5.1.4. Challenges
    • 5.1.4.1. Prevalence of counterfeit products with codeine
• 5.2. Market Segmentation Analysis
  • 5.2.1. Formulation: Syrup preferred over other formulations owing to higher patient compliance
  • 5.2.2. Applications: Codeine recognized as a suppressor of cough reflex in respiratory conditions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Codeine Market, by Formulation

• 6.1. Introduction
• 6.2. Capsule
• 6.3. Syrup
• 6.4. Tablet

7. Codeine Market, by Grade

• 7.1. Introduction
• 7.2. Laboratory Grade
• 7.3. Pharmaceutical Grade

8. Codeine Market, by Application

• 8.1. Introduction
• 8.2. Cough Suppression
• 8.3. Diarrhea Suppression
• 8.4. Pain Management

9. Codeine Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline
  • 9.2.1. Hospitals & Clinics
  • 9.2.2. Pharmacies
• 9.3. Online

10. Codeine Market, by End-User

• 10.1. Introduction
• 10.2. Adults
• 10.3. Pediatrics

11. Americas Codeine Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Codeine Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Codeine Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Advancements in Developing Enhanced Pain Relief Medications
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Accord Healthcare by Intas Pharmaceuticals
• 3. Advik Pharma
• 4. AstraEureka Pharmaceuticals
• 5. Bristol Laboratories Limited
• 6. Crescent Pharma Limited
• 7. Johnson Matthey Plc
• 8. Noramco, Inc.
• 9. Omnica Laboratories
• 10. Pfizer Inc.
• 11. Professional Compounding Centers of America, Inc.
• 12. SANOFI WINTHROP INDUSTRIE
• 13. Sun Pharmaceutical Industries Ltd.
• 14. Teva Pharmaceutical Industries Ltd.